Skip to main content
Have a personal or library account? Click to login
The Phosphodiesterase-5 Inhibitors and Prostate Cancer – What We Rely Know About It? Cover

The Phosphodiesterase-5 Inhibitors and Prostate Cancer – What We Rely Know About It?

Open Access
|Jul 2022

Full Article

ABBREVIATIONS

BPH -

Benign prostatic hyperplasia

cAMP -

Cyclic adenosine 3’,5’ monophosphate

cGMP -

Cyclic guanosine 3’,5’ monophosphate

ED -

Erectile dysfunction

FAP-1 -

Fas associated phosphatase-1

FLIP -

FLICE-like inhibitory protein

GAF -

Allosteric cGMP binding sites

iNOS -

Inducible NO synthase

MnSOD -

Manganese superoxide dismutase

mRNA -

Messenger RNA

NO -

Nitric oxide

NSRP -

Nerve-sparing radical prostatectomy

PCSC -

Prostatic cancer stem cells

PDE -

Phosphodiesterase

PDE5Is -

Phosphodiesterase-5 inhibitors

PKA -

Protein kinase A

PKG -

Protein kinase G

PP1 -

Protein phosphatase 1

PSA -

Prostate-specific antigen

sGC -

Soluble guanylyl cyclase

TRUS -

ten-core transrectal ultrasound

DOI: https://doi.org/10.1515/sjecr-2017-0073 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Page range: 175 - 184
Submitted on: Dec 19, 2017
Accepted on: Dec 28, 2017
Published on: Jul 11, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services

© 2022 Dejan Simic, Aleksandar Spasic, Mirko Jovanovic, Predrag Maric, Radovan Milosevic, Ivan Srejovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.